自拟三金补肾汤联合坦索罗辛对肾草酸钙结石患者的作用
遵义市播州区中医院
目的 探讨自拟三金补肾汤联合坦索罗辛对肾草酸钙结石患者的干预效果。方法 选取2025年2月至2026年2月遵义市播州区中医院收治的70例肾草酸钙结石患者,采用随机数表法分组,每组35例。对照组实施坦索罗辛单药治疗,研究组在对照组基础上加用自拟三金补肾汤联合干预。比较两组不同时间点结石排净率、中医证候积分、肾绞痛发作频率及用药安全性。结果 研究组治疗4周结石排净率、治疗8周结石排净率均高于对照组(P<0.05);治疗4周后,研究组腰酸痛、排尿不畅、小便涩痛、血尿积分均低于对照组(P<0.05);治疗第1~4周,研究组每周肾绞痛发作次数均少于对照组(P<0.05);两组不良反应相近(P>0.05)。结论 自拟三金补肾汤联合坦索罗辛可有效提升肾草酸钙结石患者的结石排净效率,快速缓解临床症状,减少肾绞痛发作,且安全性可靠。
Objective To investigate the intervention effects of self-formulated Sanjin Bu Shen Decoction combined with tamsulosin in patients with renal calcium oxalate stones. Methods A total of 70 patients with renal calcium oxalate stones admitted to the Bozhou District Hospital of Traditional Chinese Medicine, Zunyi City from February 2025 to February 2026 were enrolled and divided into two groups using a random number table method, with 35 cases in each group. The control group received tamsulosin monotherapy, while the study group received self-formulated Sanjin Bu Shen Decoction in addition to tamsulosin. The stone clearance rate, Traditional Chinese Medicine syndrome scores, frequency of renal colic episodes at different time points, and medication safety were compared between the two groups. Results The stone clearance rate at 4 weeks and 8 weeks of treatment in the study group was significantly higher than that in the control group, respectively(P<0.05). After 4 weeks of treatment, the scores of lumbosacral soreness, poor urination, difficult and painful urination, and hematuria in the study group were significantly lower than those in the control group(P<0.05). From week 1 to week 4 of treatment, the frequency of renal colic episodes per week in the study group was significantly lower than that in the control group(P<0.05). The incidence of adverse reactions was similar between the two groups(P>0.05). Conclusion Self-formulated Sanjin Bu Shen Decoction combined with tamsulosin can effectively improve the stone clearance rate, rapidly alleviate clinical symptoms, and reduce the frequency of renal colic episodes in patients with renal calcium oxalate stones, with a reliable safety profile.
引用本文
按标准格式复制,或导出到文献管理软件参考文献
共 14 条- [1]池睿,韩善梅,叶世华,等.排石汤联合坦索罗辛、氢氯噻嗪治疗输尿管下段结石的临床效果[J].中国当代医药,2026,33(7):38-41.
- [2]张旺龙,曹祥茂,阴伟林,等.通淋固本汤加减联合盐酸坦索罗辛在体外冲击波碎石术后直径<2 cm上尿路结石患者中的应用效果[J].现代生物医学进展,2025,25(22):3581-3589.
- [3]张传国,任伟东,张辰熙,等.石淋清颗粒激活AMPK/SIRT3信号轴诱导巨噬细胞M2极化抑制大鼠草酸钙结石形成的机制[J].中国医院药学杂志,2026,46(1):17-25.
- [4]陈周,高加胜,胡汪,等.结石通胶囊联合坦索罗辛对输尿管结石患者术后结石排净率及血清指标的影响[J].天津药学,2025,37(7):833-837.
- [5]吴孟超,吴在德.黄家驷外科学(第8版)[M].北京:人民卫生出版社,2021.
- [6]郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.
- [7]宗益平,张俊麒,王子杰,等.广金钱草总黄酮抑制M1型巨噬细胞极化减少小鼠肾草酸钙结石形成[J].南京医科大学学报(自然科学版),2025,45(3):327-333.
- [8]刘伟锋,陈文哲,曾国华.植物提取物抑制肾草酸钙结石形成的研究进展[J].中华泌尿外科杂志,2024,45(5):405-408.
- [9]张海旺,张洪海,田泽阳,等.排石汤对草酸钙泌尿系结石患者尿液成分的影响[J].国际泌尿系统杂志,2024,44(1):98-101.
- [10]冀家源,阮极盟,陈美元,等.金钱草及广金钱草对大鼠肾草酸钙结石相关代谢产物作用的研究[J].国际外科学杂志,2023,50(6):370-374.
- [11]张智源,左庆军,宋旭,等.金钱草提取物介导P38MAPK通路对大鼠草酸钙结石形成的干预效果及机制研究[J].四川中医,2022,40(10):55-58.
- [12]沙聪威,陈文政,曾木达,等.鸡内金对大鼠肾草酸钙结石的防治作用研究[J].中华全科医学,2022,20(9):1473-1476.
- [13]尹银华,胡莹,谢彩英,等.尿石汤配方颗粒对大鼠草酸钙结石肾脏的保护作用[J].今日药学,2021,31(2):119-123.
- [14]尹银华,胡莹,宋叶,等.尿石汤配方颗粒改善肾草酸钙结石大鼠肾功能效果及其机制[J].中国医院药学杂志,2021,41(1):17-23.
| 文章编号 | 2026-07-053(期号内编号) |
|---|---|
| 栏目 | 中医学研究 |
| 作者 | 蔡宏佳;唐恩明;田应勇;曾凡毅;程绍红;杨顺 |
| 作者单位 | 遵义市播州区中医院 |
| 基金项目 | 贵州省中医药管理局中医药、民族医药科学技术研究课题合同书(QZYY-2025-149) |
| 中图分类号 | R692.4 |
| 卷期页码 | 2026, 2(07): 209-212 |
| 发布时间 | 2026-10-15 |
| 出版时间 | 2026-10-15 |
| 引用信息 | [1]蔡宏佳,唐恩明,田应勇,等.自拟三金补肾汤联合坦索罗辛对肾草酸钙结石患者的作用[J].疾病预防与控制,2026,2(07):209-212. |
| 全文地址 | 在知网查看该文(kns.cnki.net) |
| 数据抓取时间 | 2026-11-03T03:31:40 |